Simplex Trading’s Constellation Pharmaceuticals, Inc. CNST Stock Holding History

Simplex Trading’s Portfolio CNST Stock Details CNST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-6,800	Closed	-$229K	–	10034
2021 Q2	$229K	Buy	6,800 +6,651	+4,464%	+$169K	﹤0.01%	5474
2021 Q1	$348K	Sell	149 -37	-20%	-$1.12K	﹤0.01%	3941
2020 Q4	$535K	Buy	186 +185	+18,500%	+$4.66K	﹤0.01%	3340
2020 Q3	$2K	Sell	1 -4	-80%	-$98	﹤0.01%	7491
2020 Q2	$15K	Sell	5 -5	-50%	-$180	﹤0.01%	6430
2020 Q1	$31K	Buy	10 +8	+400%	+$278	﹤0.01%	5611
2019 Q4	$9K	Buy	+2	New	+$58	﹤0.01%	6463

Simplex Trading's CNST Position: Q2 2021 in Review

Simplex Trading sold out of Constellation Pharmaceuticals, Inc. (CNST) in Q2 2021, closing a stake of 9,492 shares — an estimated $242K sold.

Simplex Trading first reported a position in CNST in Q4 2019 and held it in 5 quarters. The position peaked at $222K in Q1 2021. 153 funds tracked by Wall St. Rank hold CNST as of Q2 2021.

Simplex Trading reported no remaining Constellation Pharmaceuticals, Inc. position as of Q2 2021 after selling out during the quarter.
Simplex Trading sold 9,492 Constellation Pharmaceuticals, Inc. shares in Q2 2021, an estimated $242K.
Simplex Trading first reported a position in Constellation Pharmaceuticals, Inc. in Q4 2019 and held it in 5 quarters.
Simplex Trading's Constellation Pharmaceuticals, Inc. position peaked at $222K in Q1 2021.
153 funds tracked by Wall St. Rank held Constellation Pharmaceuticals, Inc. as of Q2 2021.

Based on Simplex Trading's 13F filing for Q2 2021, filed 12 Aug 2021.